Loading
Latest filing published 21 May 2026 for Nightingale Health Oyj, €5.0M.
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
All filings by Cor Group Oy on record concern Nightingale Health Oyj. Over a trading history stretching from 10 February 2023 to 18 May 2026, the count stands at 4 filings.
No open-market sale appears; the market trades are 3 purchases worth €7.8M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2026 alone, the filings show 1 purchase and no sales.
In size, the median ticket on the buying side is €1.7M. As a share of market capitalisation, the median purchase stands at 2.9%, based on 3 purchases. Across 3 purchases, this insider has always bought alone, with no colleague buying within 30 days. After 3 purchases with a full 90-day history, the hit rate stands at 67% and the median 90-day move at +5.2%. These figures describe past trades and do not predict future prices.
The latest filing, published on 21 May 2026, reports an open-market purchase of €5.0M in Nightingale Health Oyj. The median gap between a trade and its publication by Nasdaq Helsinki is 3 days. The regulation allows three business days to notify a trade (MAR article 19). Source: insider filings from Nasdaq Helsinki. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations